Sandoz is a global leader in generic and biosimilar medicines, with a growth strategy driven by its purpose: pioneering access for patients.

More than 20,000 people of 100 nationalities work together to ensure 900 million patient treatments are provided by Sandoz, generating substantial global health care savings and an even larger social impact.

This documentary explores the vital role of biosimilars in global health care. These essential medicines have become the standard of care for many chronic and critical conditions and offer an economically viable solution to expanding patient access to cutting-edge biologic treatments. Featuring interviews with leading Sandoz scientists, the film offers an exclusive glimpse into the state-of-the-art Biosimilar Development Center of Excellence in Holzkirchen, Germany.

For more information on Sandoz, visit: www.sandoz.com

This documentary is part of the FIP: Pharmacy for All, an official series of the International Pharmaceutical Federation, brought to you by Special Interest Films.